Download PDF
Exp Clin Endocrinol Diabetes 1990; 95(3): 315-321
DOI: 10.1055/s-0029-1210971
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Permissive Action of Glucocorticoid Substitution Therapy on the Effects of Atrial Natriuretic Peptide (hANP) in Patients with Adrenocortical Insufficiency

P. Damjancic, H. Vierhapper
  • Division of Clinical Endocrinology and Diabetology, I. Medical Clinic (Head : Prof. Dr. Dr. Waldhäusl), University of Vienna Austria
Further Information

Publication History

1989

Publication Date:
16 July 2009 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

To study the potential impact of glucocorticoids on the effects of human atrial natriuretic peptide (hANP) in man, the diuretic and natriuretic response to intravenous bolus doses of hANP (50 and 100 μg) was studied in seven male patients with deficient endogenous glucocorticoid synthesis, both during withdrawal of glucocorticoid therapy and during subsequent substitution with dexamethasone.

Plasma concentrations of ACTH, though markedly suppressed by dexamethasone as compared to the unsubstituted state were not influenced by exogenous hANP either during deprival or substitution of glucocorticoids. Basal plasma concentrations of hANP were 10.3 ± 8.4 pmol/1 and 19.3 ± 11.1 pmol/1 during glucocorticoid withdrawal and following substitution with dexamethasone, respectively. When substituted with glucocorticoids, patients responded to hANP (100 μg) with an increase (p < 0.025) in diuresis and sodium excretion, whereas no changes in diuresis and sodium excretion were seen following intravenous hANP during glucocorticoid withdrawal. These results suggest that glucocorticoids may have a permissive effect on hANP-mediated natriuresis and diuresis.

Key words

Atrial natriuretic peptide - Adrenocortical insufficiency - Glucocorticoids

      >